Skip to main content

Table 5 In silico analysis of the MLH1, MSH2 and MSH6 variants

From: Prevalence and spectrum of MLH1, MSH2, and MSH6 pathogenic germline variants in Pakistani colorectal cancer patients

Gene

Coding variants

In silico predictions

 

AlignGVGD

PolyPhen2

SIFT

MutPred

SNPs&GO

PhD-SNP

SNAP

Consensusa

MLH1

c.1913G > T (G638 L)

C15

Probably damaging

Deleterious

Benign

Neutral

Neutral

Neutral

B (3/7)

c.1919C > T (P640L)

C65

Probably damaging

Deleterious

Deleterious

Disease

Disease

Disease

LP (7/7)

MSH2

c.944G > T (G315 V)

C0

Benign

Deleterious

Benign

Neutral

Neutral

Neutral

B (1/7)

c.1074G > C (E358D)

C35

Possibly damaging

Tolerated

Benign

Neutral

Disease

Neutral

B (3/7)

c.2120G > A (C707Y)

C0

Probably damaging

Damaging

Benign

Disease

Disease

Disease

LP (5/7)

MSH6

c.3151G > A (V1051I)

C0

Benign

Tolerated

Benign

Neutral

Neutral

Neutral

B (0/7)

Noncoding variants

Splice-site predictions

 

SpliceSiteFinder-like

MaxEntScan

NNSPLICE

GeneSplicer

HumanSpliceSite Finder

Consensusb, c

MLH1

c.116 + 3A > T

D (75.7 → 0)

D (8.6 → 2.4)

D (0.9 → 0)

D (5.5 → 0)

NE

LP (4/5)

c.116 + 4C > A

NE

NE

NE

NE

NE

B (0/5)

c.1990-26 T > C

NE

NE

NE

NE

NE

B (0/5)

MSH2

c.2006-36_2006-33dup

NE

NE

NE

NE

NE

B (0/5)

MSH6

c.457 + 50 T > A

NE

NE

NE

NE

NE

B (0/5)

c.3556 + 170del

NE

NE

NE

NE

NE

B (0/5)

c.4001 + 26A > G

NE

D (0 → 2.9)

NE

NE

D (0 → 71.4)

B (2/5)

  1. B Benign, D Donor, LP Likely pathogenic, NE No effect
  2. aThe variant is considered as likely pathogenic by five of the seven protein function prediction algorithms
  3. b The variant is considered as likely pathogenic by four of the five splice-site prediction algorithms
  4. c > 20% change in score (i.e., a wild-type splice-site score decreases and/or a cryptic splice-site score increases) is considered as significant